Diabetic Endothelium Dysfunction, Cardiovascular Complications, and Therapeutics

J Diabetes Res. 2016:2016:5349801. doi: 10.1155/2016/5349801. Epub 2016 Feb 18.

Authors

Yunzhou Dong¹, Yong Wu², Hyoung Chul Choi³, Shuangxi Wang⁴

Affiliations

¹ Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
² Department of Internal Medicine, Charles R. Drew University of Medicine and Science and the University of California, Los Angeles, CA 90059, USA.
³ Department of Pharmacology, Yeungnam University, Daegu 712-749, Republic of Korea.
⁴ The Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital, Shandong University, Jinan 250012, China.

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / metabolism
Cardiovascular Diseases* / physiopathology
Cardiovascular Diseases* / prevention & control
Diabetic Angiopathies* / diagnosis
Diabetic Angiopathies* / metabolism
Diabetic Angiopathies* / physiopathology
Diabetic Angiopathies* / prevention & control
Endothelial Progenitor Cells / metabolism
Endothelial Progenitor Cells / pathology
Endothelium, Vascular / metabolism
Endothelium, Vascular / pathology
Endothelium, Vascular / physiopathology*
Humans
Hypoglycemic Agents / therapeutic use
Neovascularization, Pathologic

Substances

Hypoglycemic Agents

Grants and funding

SC1 CA200517/CA/NCI NIH HHS/United States